DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Beta Drugs Limited — Outcome of Board Meeting

NSE 52 min ago·18 Aug 2026, 6:37 am

Beta Drugs

Beta Drugs Limited has announced the outcome of its board meeting held on August 18, 2026. While the company has not disclosed specific details in the exchange filing, such announcements often cover critical corporate actions like board appointments, strategic reviews, or updates on ongoing projects.

For investors, this news serves as a routine update on the company's governance and future direction. The market will likely focus on whether any significant decisions were made that could impact the company's financial outlook or operational strategy.

Investors should wait for the formal press release or detailed filing to understand the full context. Until then, it is advisable to monitor the stock for any volatility driven by speculation and to look for clarity on the specific agenda items discussed by the board.